Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer. Eisses B, van Geel JJL, Brouwers AH, Bensch F, et al. J Nucl Med 2024 Sep 5:jnumed.124.267636. doi: 10.2967/jnumed.124.267636.

Read + Share

Amedeo Smart

Independent Medical Education

Eisses B, van Geel JJL, Brouwers AH, Bensch F, et al. Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer. J Nucl Med 2024 Sep 5:jnumed.124.267636. doi: 10.2967/jnumed.124.267636.
PMID: 39237347